Delivery Order SPE2DB22D2007-SPE2DB25FJ2MR
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JATENZO 198 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $1,688.17 and a completion date of June 30, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with a firm fixed price of $3,365.22 and a period of performance through May 16, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,217.27, is for the supply of JATENZO 158 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the medication JATENZO 237 MG CAPSULE 120S. The contract has a firm fixed price, a ceiling value of $2,263.74, and a period of performance ending on May 22, 2025. The contract is not set aside and was awarded on May 21, 2025. AmerisourceBergen Drug Corp is the prime contractor for this delivery order, which is part of a larger...
- The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $2,703.38 for the supply of 4,564,259,813 units of the pharmaceutical product JATENZO 237 MG CAPSULE 120S. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,317.93, is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,492.24 firm fixed-price delivery order is for the supply of 120 capsules of the prescription drug JATENZO 198 MG. The contract has an ultimate completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.88 contract is for the supply of JATENZO 198 MG CAPSULE 120S, a medication, to be delivered by June 10, 2025. This order is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,209.56, is for the delivery of JATENZO 158 MG CAPSULE 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 10, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,094.06 firm fixed price contract is for the supply of JATENZO 198 MG CAPSULE 120S, a pharmaceutical product. The award date is September 13, 2024, with an ultimate completion date of September 16, 2024. This delivery order is placed under one of Amerisourcebergen's Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued at up to...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2MRDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jatenzo 198 mg capsules in quantities of 120. The contract has a firm fixed price of $1,247.44 and a completion date of June 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/25/25 |